Great Expectations for CPhI Worldwide 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Great Expectations for CPhI Worldwide 2012



This year’s CPhI Worldwide event is set to take place at the Feria de Madrid in Spain, October 9–12, with expectations for more than 30,000 visitors and 2200 exhibitors from 140 countries. Despite the continuing troubled economic times, the show continues to boast growth; 108 new companies are preparing to join the many returning exhibitors, while the number of exhibitors in the ICSE logistics and supply chain zone will double compared with 2011. Indeed, this year will see the highest number of exhibitors compared with any previous year.

Recently, the organisers of CPhI, UBM, have been introducing a zoning structure to many of their events and this format will be present in Madrid to help facilitate navigation. The zones featured will be:

  • CPhI Worldwide: APIs; Generic APIs; Custom Manufacturing; Fine Chemicals; Intermediates; Excipients/Formulations; Biopharmaceuticals; General
  • ICSE: Logistics and Supply Chain; BioServices; Analytical & Lab Services; Pre Clinical Trials, Clinical Trials Stages 1-4, CRO, Clinical Data Management Zone; Trial Stages; New Exhibitors; North America Zone; General Floor
  • P-MEC Europe: LABWorld
  • InnoPack: Labelling

In addition, the events will be divided into global pavilions to help visitors quickly locate suppliers from specific regions. The pavilions will feature Argentina, Brazil, China, Egypt, France, India, Ireland, Korea, Morocco, North America, Portugal, Scotland and the UK. Madrid will also see the introduction of pavilions for Russia and Malaysia.

The 2012 event will also see an expansion of the CPhI Innovation Awards, which are being rebranded as the CPhI Pharma Awards for 2012. In addition, the Innovation award category has been expanded to look at showcasing exhibitors with groundbreaking innovations in formulation, drug delivery, chemical manufacturing of APIs and intermediates, and biomanufacturing of biopharmaceuticals and intermediates. You can find out more about the awards here.

The Pharmaceutical Technology and Pharmaceutical Technology Europe teams will be in attendance at the show in Hall 10, Stand A23. We look forward to meeting with you and hearing your thoughts about the show.

You can read all of CPhI news here.

CPhI was held in Madrid for the first time in 2009. Did you attend? What did you think of the location? And are you happy that the show is returning to Madrid? Let me know your thoughts in a comment!

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
38%
Breakthrough designations
13%
Protecting the supply chain
38%
Expedited reviews of drug submissions
13%
More stakeholder involvement
0%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
USP Faces New Challenges

Click here